Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral blood progenitor cell transplantation.

Jan Jansen1, James M Thompson, Michael J Dugan

  • 1Indiana Blood and Marrow Transplantation, Indianapolis, Indiana 46237, USA. jjansen@ibmtindy.com

Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
|March 12, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Antarctic Seafloor Annotated Imagery Database.

Scientific data·2026
Same author

Representativeness of the Natura 2000 network for preserving plant biodiversity in the European Union.

Conservation biology : the journal of the Society for Conservation Biology·2025
Same author

Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation.

JCO oncology practice·2025
Same author

Pemigatinib for Myeloid/Lymphoid Neoplasms with <i>FGFR1</i> Rearrangement.

NEJM evidence·2025
Same author

Best Case/Worst Case-ICU: protocol for a multisite, stepped-wedge, randomised clinical trial of scenario planning to improve communication in the ICU in US trauma centres for older adults with serious injury.

BMJ open·2024
Same author

Restrictive Strategy vs Usual Care for Cholecystectomy in Patients With Abdominal Pain and Gallstones: 5-Year Follow-Up of the SECURE Randomized Clinical Trial.

JAMA surgery·2024

Peripheral blood progenitor cells (PBPCs) are now preferred over bone marrow for stem cell transplants. PBPC transplants offer faster recovery but may increase graft-versus-host disease risks.

Area of Science:

  • Hematology
  • Stem Cell Transplantation
  • Immunology

Background:

  • Peripheral blood progenitor cells (PBPCs) have largely replaced bone marrow (BM) for autologous and increasingly for allogeneic stem cell transplantation.
  • Mobilization techniques, including G-CSF and chemotherapy, are essential to increase PBPC yields for successful transplantation.
  • Leukapheresis efficiently collects sufficient CD34+ cells for prompt engraftment.

Discussion:

  • Autologous PBPC transplants demonstrate faster hematologic recovery compared to BM transplants with minimal drawbacks.
  • Allogeneic PBPC transplants achieve faster engraftment but are associated with a higher incidence of chronic graft-versus-host disease (GvHD).
  • The increased GvHD in allogeneic PBPC transplants presents a dual effect, potentially enhancing graft-versus-tumor activity while increasing morbidity.

Related Experiment Videos

Key Insights:

  • PBPCs are a superior source for stem cell transplantation, offering faster engraftment in both autologous and allogeneic settings.
  • Mobilization and leukapheresis are critical for achieving adequate PBPC collection.
  • The balance between therapeutic benefits and GvHD risks in allogeneic PBPC transplantation requires careful consideration.

Outlook:

  • Continued research into hematopoietic and earlier stem cell biology will further refine PBPC transplantation protocols.
  • Understanding and mitigating GvHD while maximizing graft-versus-tumor effects remain key challenges.
  • PBPC transplantation is poised for further evolution, driven by advances in stem cell science.